Biểu đồ giá cổ phiếu APUS
APUS Dự đoán giá cổ phiếu
Apimeds Pharmaceuticals US Inc
$0
0%
$0
Khi đóng cửa: Jun 26, 16:00:00 GMT-4
$0
0%
$0
Phiên sau giờ: Jun 26, 19:44:13 GMT-4
Quay lại
Apimeds Pharmaceuticals US Inc (APUS) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
--
Tỷ suất cổ tức
--
EPS (TTM)
--
Vốn hóa thị trường
--
APUS là gì?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
